Hepatic fibrosis represents a critical step in the transformation of normal liver cells to HCC [95], and CXXC5 expression is down-regulated during the activation of hepatic stellate cells, which inhibits the expression of the proto-oncogene MYCL1 by binding to the promoter region of the MYCL1 gene. The gene discussed is MYCL; the disease is Hepatic fibrosis.